migraines

Investigational drug appears beneficial in preventing migrainesLilly's galcanezumab proves successful in three phase 3 migraine studies. Here are the findings.
‘Game changing’ migraine drugs on the horizonThere’s no silver bullet for migraine treatments, but treatments are getting more precise as we learn more about the cause of migraines.
FDA drug approvals-May 2015FDA actions in brief, complete response, breakthrough therapy designation, fast-track designations, orphan drug designations
Study assesses best treatments to use when a migraine attack occursIt is important to ensure established migraine medications are available for the patients who need them, according to a new study published in the January issue of Headache.
Relieve migraines with tinted contact lensesOptometric practices offer tinted and colored contact lenses to aid in cosmetic enhancement; however, many eyecare practices are unaware of the therapeutic effects that tinting a lens (contact or spectacle) can offer.
FDA drug approvals-January 2015FDA actions in brief, recommendations for approval, fast-track designations.
FDA Drug Approvals: April 2014FDA actions in brief, fast-track designation, orphan drug designation, first-time generic approvals
February FDA drug approvalsFDA actions in brief, complete response, breakthrough therapy designation, fast-track designation
Therapy plus amitriptyline reduces migraine daysCognitive behavioral therapy (CBT) combined with amitriptyline results in fewer days with headache and migraine disability in kids and teenagers with chronic migraine than does education about migraines and the tricyclic antidepressant.
Risk of rosacea higher in females with migraines
Risk of rosacea higher in females with migrainesWomen who suffer from migraines may have a slightly higher risk of rosacea, a study suggests.